CoChat

Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway

Open access
Castaño, Patricia Rodríguez, Parween, Shaheena, Pandey, Amit V · 2019 · International Journal of Molecular Sciences

Published version of a preprint

Cited by 72

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Turmeric, a popular ingredient in the cuisine of many Asian countries, comes from the roots of the Curcuma longa and is known for its use in Chinese and Ayurvedic medicine. Turmeric is rich in curcuminoids, including curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Curcuminoids have potent wound healing, anti-inflammatory, and anti-carcinogenic activities. While curcuminoids have been studied for many years, not much is known about their effects on steroid metabolism. Since many anti-cancer drugs target enzymes from the steroidogenic pathway, we tested the effect of curcuminoids on cytochrome P450 CYP17A1, CYP21A2, and CYP19A1 enzyme activities. When using 10 µg/mL of curcuminoids, both the 17α-hydroxylase as well as 17,20 lyase activities of CYP17A1 were reduced significantly. On the other hand, only a mild reduction in CYP21A2 activity was observed. Furthermore, CYP19A1 activity was also reduced up to ~20% of control when using 1–100 µg/mL of curcuminoids in a dose-dependent manner. Molecular docking studies confirmed that curcumin could dock onto the active sites of CYP17A1, CYP19A1, as well as CYP21A2. In CYP17A1 and CYP19A1, curcumin docked within 2.5 Å of central heme while in CYP21A2 the distance from heme was 3.4 Å, which is still in the same range or lower than distances of bound steroid substrates. These studies suggest that curcuminoids may cause inhibition of steroid metabolism, especially at higher dosages. Also, the recent popularity of turmeric powder as a dilatory supplement needs further evaluation for the effect of curcuminoids on steroid metabolism. The molecular structure of curcuminoids could be modified to generate better lead compounds with inhibitory effects on CYP17A1 and CYP19A1 for potential drugs against prostate cancer and breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms20184606

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 85

  1. Schraufstatter, 1949, Antibacterial action of curcumin and related compounds, Nature, 164, 456, 10.1038/164456a0 · doi:10.1038/164456a0
  2. Ammon, 1991, Pharmacology of Curcuma longa, Planta Med., 57, 1, 10.1055/s-2006-960004 · DOI · Paper page
  3. Parsai, 2014, Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives, Oncol. Lett., 7, 17, 10.3892/ol.2013.1679 · DOI
  4. Priyadarsini, 2009, Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells, J. Photochem. Photobiol. C Photochem. Rev., 10, 81, 10.1016/j.jphotochemrev.2009.05.001 · DOI · Paper page
  5. Kumar, 2016, Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives, Life Sci., 148, 313, 10.1016/j.lfs.2016.02.022 · DOI
  6. Jagetia, 2007, Spicing up of the immune system by curcumin, J. Clin. Immunol., 27, 19, 10.1007/s10875-006-9066-7 · DOI · Paper page
  7. Han, 2017, Curcuma Longa as Medicinal Herb in the Treatment of Diabetic Complications, Acta Pol. Pharm., 74, 605
  8. Khaliq, 2015, Recent Progress for the Utilization of Curcuma longa, Piper nigrum and Phoenix dactylifera Seeds against Type 2 Diabetes, West Indian Med. J., 64, 527
  9. Guo, W., Wu, X., Li, Y., Gao, J., Wang, F., Jin, Y., Chong, T., and Malhotra, A. (2019). Evaluation of biophysical as well as biochemical potential of curcumin and resveratrol during prostate cancer. J. Drug Target., 1–21. · DOI
  10. Chendil, 2004, Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3, Oncogene, 23, 1599, 10.1038/sj.onc.1207284 · DOI · Paper page
  11. Nakamura, 2002, Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines, Int. J. Oncol., 21, 825
  12. Ohtsu, 2002, Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents, J. Med. Chem., 45, 5037, 10.1021/jm020200g · DOI · Paper page
  13. Chen, 2018, Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer, Int. J. Oncol., 52, 579
  14. Zhou, 2016, Pyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation, Oncol. Lett., 11, 4160, 10.3892/ol.2016.4536 · DOI
  15. Sharma, 2016, Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin, Mol. Cell. Endocrinol., 431, 12, 10.1016/j.mce.2016.04.024 · DOI
  16. Mandalapu, 2016, Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines, Bioorg. Med. Chem. Lett., 26, 4223, 10.1016/j.bmcl.2016.07.053 · DOI
  17. Jordan, 2016, Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment, Life Sci., 152, 135, 10.1016/j.lfs.2016.03.036 · doi:10.1016/j.lfs.2016.03.036
  18. Chen, 2015, Curcumin-based anti-prostate cancer agents, Anticancer Agents Med. Chem., 15, 138, 10.2174/1871520615666150116102442 · doi:10.2174/1871520615666150116102442
  19. Hosseini, 2018, Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review, Biomed. Pharm. Biomed. Pharm., 99, 411, 10.1016/j.biopha.2018.01.072 · DOI
  20. Anand, 2007, Bioavailability of curcumin: Problems and promises, Mol. Pharm., 4, 807, 10.1021/mp700113r · DOI · Paper page
  21. Anand, 2008, Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature, Biochem. Pharm., 76, 1590, 10.1016/j.bcp.2008.08.008 · DOI · Paper page
  22. Mach, 2010, Evaluation of liposomal curcumin cytochrome p450 metabolism, Anticancer Res., 30, 811
  23. Thangapazham, 2008, Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells, Int. J. Oncol., 32, 1119
  24. Yallapu, 2012, Design of curcumin loaded cellulose nanoparticles for prostate cancer, Curr. Drug Metab., 13, 120, 10.2174/138920012798356952 · DOI
  25. Yallapu, 2014, Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer, Biomaterials, 35, 8635, 10.1016/j.biomaterials.2014.06.040 · DOI · Paper page
  26. Francis, 2015, Future of nano bisdemethoxy curcumin analog: Guaranteeing safer intravenous delivery, Environ. Toxicol. Pharm., 39, 467, 10.1016/j.etap.2014.12.018 · doi:10.1016/j.etap.2014.12.018
  27. Chang, 2015, Curcumin, encapsulated in nano-sized PLGA, down-regulates nuclear factor kappaB (p65) and subarachnoid hemorrhage induced early brain injury in a rat model, Brain Res., 1608, 215, 10.1016/j.brainres.2015.02.039 · DOI
  28. Young, N.A., Bruss, M.S., Gardner, M., Willis, W.L., Mo, X., Valiente, G.R., Cao, Y., Liu, Z., Jarjour, W.N., and Wu, L.C. (2014). Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFkappaB signaling and macrophage migration. PLoS ONE, 9. · DOI
  29. Ipar, 2019, Enhancing Curcumin Oral Bioavailability Through Nanoformulations, Eur. J. Drug Metab. Pharm., 44, 459, 10.1007/s13318-019-00545-z · DOI · Paper page
  30. Kushwaha, 2018, Combinatorial drug delivery strategy employing nano-curcumin and nano-MiADMSA for the treatment of arsenic intoxication in mouse, Chem. Biol. Interact., 286, 78, 10.1016/j.cbi.2018.03.006 · doi:10.1016/j.cbi.2018.03.006
  31. Yu, 2017, A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin, Mater. Sci. Eng. C Mater. Biol. Appl., 75, 25, 10.1016/j.msec.2017.02.018 · doi:10.1016/j.msec.2017.02.018
  32. Dende, 2017, Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria, Sci. Rep., 7, 10062, 10.1038/s41598-017-10672-9 · DOI
  33. Yan, 2016, Targeted nanomedicine for prostate cancer therapy: Docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo, Drug Deliv., 23, 1757, 10.3109/10717544.2015.1069423 · doi:10.3109/10717544.2015.1069423
  34. Kuttan, 1985, Potential anticancer activity of turmeric (Curcuma longa), Cancer Lett., 29, 197, 10.1016/0304-3835(85)90159-4 · DOI · Paper page
  35. Gupta, 2013, Therapeutic roles of curcumin: Lessons learned from clinical trials, Aa. J., 15, 195
  36. Miyazawa, 2018, Curcumin and piperine supplementation of obese mice under caloric restriction modulates body fat and interleukin-1β, Nutr. Metab., 15, 12, 10.1186/s12986-018-0250-6 · DOI
  37. Pufall, 2015, Glucocorticoids and Cancer, Adv. Exp. Med. Biol., 872, 315, 10.1007/978-1-4939-2895-8_14 · DOI · Paper page
  38. Malikova, 2017, CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2, J. Steroid Biochem. Mol. Biol., 74, 192, 10.1016/j.jsbmb.2017.09.007 · DOI
  39. Udhane, 2016, Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis, Biochem. Biophys. Res. Commun., 477, 1005, 10.1016/j.bbrc.2016.07.019 · DOI
  40. Shozu, 1991, A new cause of female pseudohermaphroditism: Placental aromatase deficiency, J. Clin. Endocrinol. Metab., 72, 560, 10.1210/jcem-72-3-560 · DOI · Paper page
  41. Harada, 1992, Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency, J. Biol. Chem., 267, 4781, 10.1016/S0021-9258(18)42900-6 · DOI · Paper page
  42. Simpson, 1994, Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis, Endocr. Rev., 15, 342
  43. Amalraj, 2017, Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives–A review, J. Tradit. Complement. Med., 7, 205, 10.1016/j.jtcme.2016.05.005 · DOI · Paper page
  44. Majhi, 2010, Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C, Bioorganic Med. Chem., 18, 1591, 10.1016/j.bmc.2009.12.075 · DOI
  45. Mondal, 2016, Stability of curcumin in different solvent and solution media: UV–visible and steady-state fluorescence spectral study, J. Photochem. Photobiol. B Biol., 158, 212, 10.1016/j.jphotobiol.2016.03.004 · DOI
  46. Yoon, H.J., Zhang, X., Kang, M.G., Kim, G.J., Shin, S.Y., Baek, S.H., Lee, B.N., Hong, S.J., Kim, J.T., and Hong, K. (2018). Cytotoxicity Evaluation of Turmeric Extract Incorporated Oil-in-Water Nanoemulsion. Int. J. Mol. Sci., 19. · DOI
  47. 2013, Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa), J. Altern. Complementary Med., 9, 161
  48. Gazdar, 1990, Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis, Cancer Res., 50, 5488
  49. Wang, 2012, Human adrenocortical carcinoma cell lines, Mol. Cell. Endocrinol., 351, 58, 10.1016/j.mce.2011.08.041 · DOI · Paper page
  50. Samandari, 2007, Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities, J. Endocrinol., 195, 459, 10.1677/JOE-07-0166 · DOI
  51. Lindholm, 2001, Incidence and late prognosis of cushing’s syndrome: A population-based study, J. Clin. Endocrinol. Metab., 86, 117
  52. Carmina, 2006, Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism, J. Clin. Endocrinol. Metab., 91, 2, 10.1210/jc.2005-1457 · DOI · Paper page
  53. Nakajin, 1984, C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17 alpha-hydroxylase/C17,20-lyase cytochrome P-450, J. Biol. Chem., 259, 3971, 10.1016/S0021-9258(17)43191-7 · DOI · Paper page
  54. Fernandez-Cancio, M., Camats, N., Fluck, C.E., Zalewski, A., Dick, B., Frey, B.M., Monne, R., Toran, N., Audi, L., and Pandey, A.V. (2018). Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17, 20 Lyase Deficiency. Pharmaceuticals, 11. · DOI
  55. Kim, 2015, Modulation of Hepatic Cytochrome P450 Enzymes by Curcumin and its Pharmacokinetic Consequences in Sprague-dawley Rats, Pharmacogn. Mag., 11, S580, 10.4103/0973-1296.172965 · DOI
  56. Sasaki, 2017, Effect of health foods on cytochrome P450-mediated drug metabolism, J. Pharm. Health Care Sci., 3, 14, 10.1186/s40780-017-0083-x · DOI
  57. Commandeur, 2007, Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products, Toxicology, 235, 83, 10.1016/j.tox.2007.03.007 · DOI · Paper page
  58. Montgomery, 2016, Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer, Clin. Cancer Res., 22, 1356, 10.1158/1078-0432.CCR-15-1432 · DOI
  59. Fizazi, 2015, NMulticenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5, J. Clin. Oncol., 33, 723, 10.1200/JCO.2014.56.5119 · DOI · Paper page
  60. Kaku, 2011, Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer, Bioorganic Med. Chem., 19, 6383, 10.1016/j.bmc.2011.08.066 · DOI
  61. Guan, 2017, Therapeutic effects of curcumin nanoemulsions on prostate cancer, J. Huazhong Univ. Sci. Technol. Med. Sci., 37, 371, 10.1007/s11596-017-1742-8 · doi:10.1007/s11596-017-1742-8
  62. Wang, 1997, Stability of curcumin in buffer solutions and characterization of its degradation product, J. Pharm. Biomed. Anal., 15, 1867, 10.1016/S0731-7085(96)02024-9 · DOI · Paper page
  63. Dahll, 1994, Photocytotoxicity of curcumin, Photochem. Photobiol., 59, 290, 10.1111/j.1751-1097.1994.tb05036.x · doi:10.1111/j.1751-1097.1994.tb05036.x
  64. Yuan, 2014, Self-Assembled Nanoparticles of Glycyrrhetic Acid-Modified Pullulan as a Novel Carrier of Curcumin, Molecules, 19, 13305, 10.3390/molecules190913305 · DOI
  65. Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med., 64, 353, 10.1055/s-2006-957450 · DOI · Paper page
  66. Delecroix, 2017, Curcumin and Piperine Supplementation and Recovery Following Exercise Induced Muscle Damage: A Randomized Controlled Trial, J. Sports Sci. Med., 16, 147
  67. Srivilai, 2017, Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors, Med. Chem. Res., 26, 1550, 10.1007/s00044-017-1869-y · DOI
  68. Changtam, 2010, Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species, Eur. J. Med. Chem., 45, 941, 10.1016/j.ejmech.2009.11.035 · DOI · Paper page
  69. Parohan, 2019, The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial, Nutr. Neurosci., 26, 1
  70. Rezayat, 2019, Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial, Nutr. Metab. (Lond.), 16, 8, 10.1186/s12986-019-0331-1 · DOI · Paper page
  71. Asadi, 2019, Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial, Complement Ther. Med., 43, 253, 10.1016/j.ctim.2019.02.014 · DOI · Paper page
  72. Corson, 2007, Molecular understanding and modern application of traditional medicines: Triumphs and trials, Cell, 130, 769, 10.1016/j.cell.2007.08.021 · DOI · Paper page
  73. Kohler, 1971, Isolation of Hormone-Producing Clonal Lines of Human Choriocarcinoma1, J. Clin. Endocrinol. Metabol., 32, 683, 10.1210/jcem-32-5-683 · DOI · Paper page
  74. Bird, 1993, Human NCI-H295 adrenocortical carcinoma cells: A model for angiotensin-II-responsive aldosterone secretion, Endocrinology, 133, 1555, 10.1210/endo.133.4.8404594 · doi:10.1210/endo.133.4.8404594 · Paper page
  75. Rainey, 1994, The NCI-H295 cell line: A pluripotent model for human adrenocortical studies, Mol. Cell. Endocrinol., 100, 45, 10.1016/0303-7207(94)90277-1 · DOI · Paper page
  76. Udhane, 2015, Retinoic acid receptor beta and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis, Sci. Rep., 5, 10132, 10.1038/srep10132 · DOI · Paper page
  77. Shaw, 2002, Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells, FASEB J., 16, 869, 10.1096/fj.01-0995fje · DOI · Paper page
  78. Phattanawasin, 2009, Validated TLC-Image Analysis Method for Simultaneous Quantification of Curcuminoids in Curcuma longa, Chromatographia, 69, 397, 10.1365/s10337-008-0893-y · doi:10.1365/s10337-008-0893-y
  79. Lephart, 1991, Assay of aromatase activity, Methods Enzymol., 206, 477, 10.1016/0076-6879(91)06116-K · DOI · Paper page
  80. Krieger, 2004, Making optimal use of empirical energy functions: Force-field parameterization in crystal space, Proteins, 57, 678, 10.1002/prot.20251 · DOI · Paper page
  81. DeVore, 2012, Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001, Nature, 482, 116, 10.1038/nature10743 · DOI · Paper page
  82. Pallan, 2015, Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: Structure of the enzyme·progesterone substrate complex and rate-limiting c–h bond cleavage, J. Biol. Chem., 290, 13128, 10.1074/jbc.M115.646307 · DOI · Paper page
  83. Trott, 2010, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem., 31, 455, 10.1002/jcc.21334 · DOI · Paper page
  84. Wang, 2019, Nano-Curcumin Simultaneously Protects the Blood-Brain Barrier and Reduces M1 Microglial Activation During Cerebral Ischemia-Reperfusion Injury, ACS Appl. Mater. Interfaces, 11, 3763, 10.1021/acsami.8b20594 · DOI
  85. Jaguezeski, 2019, Effect of free and nano-encapsulated curcumin on treatment and energetic metabolism of gerbils infected by Listeria monocytogenes, Microb. Pathog., 134, 103564, 10.1016/j.micpath.2019.103564 · DOI

Cited by

See all 72

Metadata

Authors
Castaño, P. R., Parween, S., & Pandey, A. V.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2019-09-17
Volume
20
Issue
18
Pages
4606
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2973896424
Cited by
72
References
18
FWCI
2.43
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.